PEOPLE - CryoCor makes appointment:
This article was originally published in Clinica
San Diego, California-based CryoCor has appointed Mark Hattendorf to its board of directors and as chairman of the audit committee. Mr Hattendorf is currently the CFO of EWI Holdings and has over 30 years' financial and senior business experience. CryoCor designs systems, based on its proprietary cryoblation technology, for minimally-invasive treatment of cardiac arrhythmias.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.